




Searching News Database: eczema
HSMN NewsFeed - 15 Sep 2022
Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
Alphyn Biologics Closes $3.3 Million Series A Financing to Advance Breakthrough Atopic Dermatitis Treatment
HSMN NewsFeed - 23 Jun 2020
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
Ortho Dermatologics Launches ARAZLO(TM) (tazarotene) Lotion, 0.045%, In The United States
HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
HSMN NewsFeed - 18 May 2020
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment
HSMN NewsFeed - 24 Oct 2019
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Amgen To Make Repatha(R) (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
HSMN NewsFeed - 30 Dec 2013
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
FDA Approves SALMONELEX(TM) Against Salmonella as New Food Processing Aid
HSMN NewsFeed - 24 Oct 2013
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
Celsus Therapeutics Announces Appointment of Pablo Jimenez, M.D., to Chief Medical Officer
HSMN NewsFeed - 14 Feb 2013
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
Santarus Announces Commercial Launch of UCERIS (budesonide) Extended Release Tablets
HSMN NewsFeed - 26 Mar 2010
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
HSMN NewsFeed - 11 Aug 2009
David Esposito Joins Phadia as Senior Vice President of U.S. Sales and Marketing
David Esposito Joins Phadia as Senior Vice President of U.S. Sales and Marketing
HSMN NewsFeed - 27 Jul 2009
Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram(R)
Ceragenix and MEGAPHARM Enter Into Distribution and Supply Agreement for EpiCeram(R)
HSMN NewsFeed - 11 Mar 2009
Basilea's Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg
Basilea's Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg
HSMN NewsFeed - 21 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in France
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in France
HSMN NewsFeed - 15 Oct 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Finland
HSMN NewsFeed - 22 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
Basilea's Toctino(R) (alitretinoin) receives marketing authorization in Denmark
HSMN NewsFeed - 8 Sep 2008
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
Basilea's Toctino(R) (alitretinoin) receives first national marketing authorization in the UK
HSMN NewsFeed - 29 Aug 2008
Pharmaderm Annnounces the Arrival of KEROL(TM) ZX and KEROL(TM) Emulsion to Market
Pharmaderm Annnounces the Arrival of KEROL(TM) ZX and KEROL(TM) Emulsion to Market
HSMN NewsFeed - 8 May 2008
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
HSMN NewsFeed - 27 Feb 2008
Manhattan Pharmaceuticals Announces Closing of Joint Venture With Nordic Biotech
Manhattan Pharmaceuticals Announces Closing of Joint Venture With Nordic Biotech
HSMN NewsFeed - 3 Feb 2008
American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema
American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema
HSMN NewsFeed - 27 Dec 2007
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
Manhattan Pharmaceuticals Names Mary C. Spellman, M.D. as Head of Dermatology and Drug Development
HSMN NewsFeed - 19 Nov 2007
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(R)
HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
HSMN NewsFeed - 28 Jun 2007
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
Bradley Pharmaceuticals Launches Kerol(TM) Topical Suspension and ROSULA(R) Clarifying Wash(TM)
HSMN NewsFeed - 7 Jun 2007
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
HSMN NewsFeed - 24 Apr 2007
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
Ceragenix Announces Results from Phase IV Study of EpiCeram(TM) Meet All Primary and Secondary Endpoints
HSMN NewsFeed - 19 Sep 2006
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
FDA Approves Connetics' Verdeso Foam for the Treatment of Mild-to-Moderate Atopic Dermatitis
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 62

Members Archive contains
62 additional stories matching:
eczema
(Password required)
eczema
(Password required)